Plain-English translation of NCT07593248 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This is a real-world study tracking about 2,000 patients in China who have had lung cancer surgery and are taking EGFR-TKI (a targeted medication that works specifically against certain lung cancer mutations). Researchers want to understand how well this medication works for patients after surgery and what happens to them over time. The study combines information from medical records already collected and regular follow-up appointments going forward.
While this medication is known to help some lung cancer patients, doctors want to learn how it performs in everyday clinical practice—not just in controlled clinical trials. Understanding real-world outcomes helps doctors and patients make better decisions about treatment and know what to expect.
You likely qualify if…
You likely don't qualify if…
You would share your medical records and health information with the study team, starting with records from before you enrolled. Then the study team would contact you every 3 months for the first year, and every 6 months after that, either through phone calls or by reviewing your medical records from your regular doctor visits. This continues until the end of the study, or until you decide to stop participating. No new medication or procedures are being tested—the study is simply tracking how you do on the medication you're already taking.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
China